Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 9Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia 2Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Hemoglobinuria, Paroxysmal 1Hematologic Neoplasms 1Congenital amegakaryocytic thrombocytopenia 1Congenital Abnormalities 1Bone Marrow Failure Disorders 1Blast Crisis 1Anemia, Hypochromic 1Anemia, Diamond-Blackfan 1

Interventions

Cyclophosphamide 29fludarabine phosphate 19Filgrastim 18Whole-Body Irradiation 15Mycophenolic Acid 15Methotrexate 15Peripheral Blood Stem Cell Transplantation 14Cytarabine 14Cyclosporine 13Busulfan 12Methylprednisolone 10Thiotepa 9Antilymphocyte Serum 9Tacrolimus 8Granulocyte Colony-Stimulating Factor 8Clofarabine 8Vincristine 7Radiotherapy 7Melphalan 7Cord Blood Stem Cell Transplantation 7fludarabine 6Leucovorin 6Dexamethasone 6merphos 5Mercaptopurine 5Etoposide 5Daunorubicin 5Cladribine 5Therapeutics 4Prednisone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Biphenotypic, Acute × treosulfan × Clear all
NCT00796068 2023-02-17

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
130 enrolled 21 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡